<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03821155</url>
  </required_header>
  <id_info>
    <org_study_id>2018-166</org_study_id>
    <nct_id>NCT03821155</nct_id>
  </id_info>
  <brief_title>Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis?</brief_title>
  <official_title>Which Treatment is Most Effective When Treating Vestibular Neuritis: Corticosteroid Treatment Alone or Combined Corticosteroid Treatment and Vestibular Rehabilitation?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate which treatment option (corticosteroid treatment alone or combined
      corticosteroid treatment and vestibular rehabilitation) is the most effective in patients
      diagnosed with vestibular neuritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients diagnosed with vestibular neuritis will we consider for enrollment. Each patient
      will undergo randomization for a specific treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients randomized to two different treatments:
corticosteroid treatment (&quot;prednisolone&quot;)
combined corticosteroid treatment (&quot;prednisolone&quot;) and vestibular rehabilitation</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Suppressing head impulse paradigm (SHIMP)</measure>
    <time_frame>6 month</time_frame>
    <description>SHIMP equipment will objectively quantify change of vestibular function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective visual vertical (SVV)</measure>
    <time_frame>6 month</time_frame>
    <description>SVV test will objectively quantify the experienced spatial orientation as an indicator of visual and vestibular otolithic function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Video head impulse test (v-HIT)</measure>
    <time_frame>6 month</time_frame>
    <description>v-HIT equipment will objectively quantify change of vestibular function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dizziness handicap inventory (DHI) questionnaire</measure>
    <time_frame>6 month</time_frame>
    <description>Fulfillment of the questionnaire &quot;Dizziness Handicap Inventory&quot; (DHI) will quantify the level of experienced vertigo.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vestibular Neuritis</condition>
  <arm_group>
    <arm_group_label>Neuritis vestibularis (group 1)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Corticosteroid (&quot;prednisolone&quot;)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neuritis vestibularis (group 2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Corticosteroid (&quot;prednisolone&quot;) + vestibular rehabilitation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vestibular rehabilitation</intervention_name>
    <description>Specialized physical therapy aimed at restoring balance</description>
    <arm_group_label>Neuritis vestibularis (group 2)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid</intervention_name>
    <description>Prednisolone</description>
    <arm_group_label>Neuritis vestibularis (group 1)</arm_group_label>
    <arm_group_label>Neuritis vestibularis (group 2)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age above 18 years of age

          2. Medical history compatible with vestibular neuritis

          3. Verification of vestibular neuritis with positive romberg test, pathological v-HIT and
             horizontal nystagmus with a rotatory component.

        Exclusion Criteria:

          1. Former medical history with vestibular dysfunction

          2. Medical history or objective signs of cochlear dysfunction before, during or after
             onset of vestibular neuritis

          3. Onset of symptoms 14 days before recruitment to the study

          4. Focal neurological symptoms/signs

          5. Contraindication to prednisolone treatment

          6. Problem with participating in vestibular rehabilitation due to muscular-skeletal
             disease ect.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan D Hougaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin H Wolder, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan D Hougaard, MD</last_name>
    <phone>97662781</phone>
    <phone_ext>0045</phone_ext>
    <email>d.hougaard@rn.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martin H Wolder, MS</last_name>
    <phone>30685964</phone>
    <phone_ext>0045</phone_ext>
    <email>m.wolder@rn.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Otolaryngology, Head &amp; Neck Surgery and Audiology</name>
      <address>
        <city>Aalborg</city>
        <state>North Denmark Region</state>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan D Hougaard, MD</last_name>
      <phone>4597662711</phone>
      <phone_ext>0045</phone_ext>
      <email>d.hougaard@rn.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 21, 2019</study_first_submitted>
  <study_first_submitted_qc>January 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg University Hospital</investigator_affiliation>
    <investigator_full_name>Dan Dupont Hougaard</investigator_full_name>
    <investigator_title>MD, Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Vestibular Neuritis</keyword>
  <keyword>SHIMP (suppressing head impulse paradigm)</keyword>
  <keyword>SVV (subjective visual vertical)</keyword>
  <keyword>Vestibular rehabilitation</keyword>
  <keyword>Prednisolone</keyword>
  <keyword>v-HIT (video head impulse test)</keyword>
  <keyword>Vestibular Neuronitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vestibular Neuronitis</mesh_term>
    <mesh_term>Neuritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

